XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 3,946,220 $ 2,073,971
General and administrative 4,230,698 1,917,030
Total operating expenses 8,176,918 3,991,001
Loss from operations (8,176,918) (3,991,001)
Other income:    
Interest income 185,143 30,690
Foreign currency transaction gain (loss) 23,070 (23,293)
Total other income, net 208,213 7,397
Net loss $ (7,968,705) $ (3,983,604)
Net loss per share - basic and diluted $ (0.79) $ (0.53)
Weighted average common shares outstanding - basic and diluted 10,087,363 7,497,433